businesspress24.com - Celsion to Present at Upcoming Investor Conferences in March 2012
 

Celsion to Present at Upcoming Investor Conferences in March 2012

ID: 1088078

(firmenpresse) - LAWRENCEVILLE, NJ -- (Marketwire) -- 02/29/12 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that management will present at the following upcoming investor conferences during the month of March 2012.

Conference: Cowen and Company 32nd Annual Health Care Conference
Date: Wednesday, March 7, 2012 at 8:00 a.m. Eastern time in Boston, MA

Conference: Roth Capital Partners 24th Annual Growth Stock Conference
Date: Tuesday, March 13, 2012 at 8:30 a.m. Pacific time in Dana Point, CA

Conference: Rodman & Renshaw 2nd Annual Life Sciences Summit
Date: Wednesday, March 21 to Friday, March 23, 2012 in Park City, UT

The Rodman & Renshaw Summit will allow institutional investors to meet with management but does not include a formal presentation.

A live audio only webcast of the presentations will be available on Celsion's website at . The webcast will be archived on the same site for replay following the conference.

Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with its heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, Kyungpook National University Hospital and the Beijing Cancer Hospital.

For more information on Celsion, visit our website: .



Investor Contact

David Pitts
Argot Partners
212-600-1902




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  MichBio to Visit Capitol Hill on Medical Device Industry Issues as Part of Coordinated National Advocacy Effort
CONMED Corporation Announces Cash Dividend Policy and Declares Initial Quarterly Cash Dividend
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 29.02.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1088078
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

LAWRENCEVILLE, NJ


Phone:

Kategorie:

Surgery & Treatments


Anmerkungen:


Diese Pressemitteilung wurde bisher 182 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Celsion to Present at Upcoming Investor Conferences in March 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von

Celsion Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Celsion Corporation



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 65


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.